Sign in

CIK 0001590560

  • Large accelerated filer

uniQure N.V.

Sign in to watch
Ticker
QURE
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Entity type
Operating
Phone
+1 339-970-7000
Business address
PAASHEUVELWEG 25A, AMSTERDAM, Netherlands, 1105 BP
Former names
uniQure B.V.
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$192,950
in 1 filing, $193K under 10b5-1 plans

Net −$192,950. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Pace of trading Bought Sold

Who's trading

90 days

  1. Meek David D. −$193K Director sold 23% of stake

Reading 100 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2025-11-04 Kaye Jack Director Exercise or conversion 10b5-1 +17,810 $14.08 $251K 38,249
2025-11-04 Kaye Jack Director Sale 10b5-1 −17,810 $30.33 $540K 20,439
2025-11-04 Kaye Jack Director Exercise or conversion · Stock Option (Right to Buy) 10b5-1 −10,000 0
2025-11-04 Kaye Jack Director Exercise or conversion · Stock Option (Right to Buy) 10b5-1 −11,000 0
2025-11-04 Kaye Jack Director Exercise or conversion · Stock Option (Right to Buy) 10b5-1 −17,810 0
2025-09-26 KLEMT CHRISTIAN Chief Financial Officer Exercise or conversion 10b5-1 +15,000 $5.37 $81K 232,730
2025-09-26 KLEMT CHRISTIAN Chief Financial Officer Sale 10b5-1 −15,000 $55.00 $825K 217,730
2025-09-26 KLEMT CHRISTIAN Chief Financial Officer Exercise or conversion · Stock Option (Right to Buy) 10b5-1 −15,000 0
2025-09-24 Kapusta Matthew C CEO, Managing Director Exercise or conversion 10b5-1 +51,316 $7.53 $386K 702,770
2025-09-24 Kapusta Matthew C CEO, Managing Director Exercise or conversion 10b5-1 +175,000 $6.22 $1.1M 877,770
2025-09-24 Kapusta Matthew C CEO, Managing Director Sale 10b5-1 −51,316 $39.59 $2.0M 826,454
2025-09-24 Kapusta Matthew C CEO, Managing Director Sale 10b5-1 −60,000 $40.04 $2.4M 766,454
2025-09-24 Kapusta Matthew C CEO, Managing Director Sale 10b5-1 −49,978 $40.68 $2.0M 716,476
2025-09-24 Kapusta Matthew C CEO, Managing Director Sale 10b5-1 −5,022 $41.69 $209K 711,454
2025-09-24 Kapusta Matthew C CEO, Managing Director Sale 10b5-1 −60,000 $45.10 $2.7M 651,454
2025-09-24 Kapusta Matthew C CEO, Managing Director Exercise or conversion · Stock Option (Right to Buy) 10b5-1 −51,316 0
2025-09-24 Kapusta Matthew C CEO, Managing Director Exercise or conversion · Stock Option (Right to Buy) 10b5-1 −175,000 0
2025-09-24 KLEMT CHRISTIAN Chief Financial Officer Exercise or conversion 10b5-1 +3,000 $13.03 $39K 220,730
2025-09-24 KLEMT CHRISTIAN Chief Financial Officer Sale 10b5-1 −3,000 $40.04 $120K 217,730
2025-09-24 KLEMT CHRISTIAN Chief Financial Officer Exercise or conversion · Stock Option (Right to Buy) 10b5-1 −3,000 0

Page 7 of 13 · 251 trades